These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
4. The Prevalence of Founder Mutations among Individuals from Families with Familial Pancreatic Cancer Syndrome. Lener MR; Kashyap A; Kluźniak W; Cybulski C; Soluch A; Pietrzak S; Huzarski T; Gronwald J; Lubiński J Cancer Res Treat; 2017 Apr; 49(2):430-436. PubMed ID: 27488870 [TBL] [Abstract][Full Text] [Related]
5. AGA Clinical Practice Update on Pancreas Cancer Screening in High-Risk Individuals: Expert Review. Aslanian HR; Lee JH; Canto MI Gastroenterology; 2020 Jul; 159(1):358-362. PubMed ID: 32416142 [TBL] [Abstract][Full Text] [Related]
7. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Ohmoto A; Yachida S; Morizane C Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30699894 [TBL] [Abstract][Full Text] [Related]
8. Genetic testing by cancer site: pancreas. Axilbund JE; Wiley EA Cancer J; 2012; 18(4):350-4. PubMed ID: 22846737 [TBL] [Abstract][Full Text] [Related]
9. Familial pancreatic cancer: Concept, management and issues. Matsubayashi H; Takaori K; Morizane C; Maguchi H; Mizuma M; Takahashi H; Wada K; Hosoi H; Yachida S; Suzuki M; Usui R; Furukawa T; Furuse J; Sato T; Ueno M; Kiyozumi Y; Hijioka S; Mizuno N; Terashima T; Mizumoto M; Kodama Y; Torishima M; Kawaguchi T; Ashida R; Kitano M; Hanada K; Furukawa M; Kawabe K; Majima Y; Shimosegawa T World J Gastroenterol; 2017 Feb; 23(6):935-948. PubMed ID: 28246467 [TBL] [Abstract][Full Text] [Related]
11. Molecular Features and Clinical Management of Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. Kasuga A; Okamoto T; Udagawa S; Mori C; Mie T; Furukawa T; Yamada Y; Takeda T; Matsuyama M; Sasaki T; Ozaka M; Ueki A; Sasahira N Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163129 [TBL] [Abstract][Full Text] [Related]
12. Germline mutations in Japanese familial pancreatic cancer patients. Takai E; Yachida S; Shimizu K; Furuse J; Kubo E; Ohmoto A; Suzuki M; Hruban RH; Okusaka T; Morizane C; Furukawa T Oncotarget; 2016 Nov; 7(45):74227-74235. PubMed ID: 27732944 [TBL] [Abstract][Full Text] [Related]
13. Familial Pancreatic Cancer and the Future of Directed Screening. Welinsky S; Lucas AL Gut Liver; 2017 Nov; 11(6):761-770. PubMed ID: 28609837 [TBL] [Abstract][Full Text] [Related]
18. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Schneider R; Slater EP; Sina M; Habbe N; Fendrich V; Matthäi E; Langer P; Bartsch DK Fam Cancer; 2011 Jun; 10(2):323-30. PubMed ID: 21207249 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families. Slater EP; Langer P; Fendrich V; Habbe N; Chaloupka B; Matthäi E; Sina M; Hahn SA; Bartsch DK Fam Cancer; 2010 Sep; 9(3):335-43. PubMed ID: 20195775 [TBL] [Abstract][Full Text] [Related]